Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 16/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.70 |
| ▸ | CSNK1D | P48730 | 8/20 | 0.67 |
| ▸ | CSNK1E | P49674 | 8/20 | 0.67 |
| ▸ | TEK | Q02763 | 1/20 | 0.52 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.51 |
| ▸ | RAF1 | P04049 | 1/20 | 0.51 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.51 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16497630 | 0.88 | ALOX5 (0.81) | MAPK14ALOX5CSNK1DCSNK1EMAPK13 | |
| SCHEMBL17002183 | 0.86 | MAPK14 (1.00) | MAPK14ALOX5CSNK1DCSNK1ETEK | |
| SCHEMBL18960503 | 0.84 | MAPK14 (0.83) | MAPK14CSNK1DCSNK1EMAPK13RAF1 | |
| SCHEMBL4552999 | 0.82 | ALOX5 (0.72) | MAPK14ALOX5CSNK1DCSNK1EMAPK13 | |
| SCHEMBL4553479 | 0.82 | ALOX5 (1.00) | MAPK14ALOX5CSNK1DCSNK1ETEK | |
| SCHEMBL2148412 | 0.81 | MAPK14 (0.69) | MAPK14ALOX5MAPK13RAF1MAPK12 | |
| SCHEMBL6605306 | 0.81 | MAPK14 (0.68) | MAPK14ALOX5CSNK1DCSNK1ETEK | |
| SCHEMBL17002182 | 0.81 | MAPK14 (1.00) | MAPK14ALOX5CSNK1DCSNK1EMAPK13 | |
| SCHEMBL17002319 | 0.81 | MAPK14 (1.00) | MAPK14ALOX5CSNK1DCSNK1EMAPK13 | |
| SCHEMBL5078817 | 0.80 | MAPK14 (0.66) | MAPK14ALOX5CSNK1DCSNK1EMAPK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10865384-B2 | 2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-12-15 | — | — | US | disclosed |
| US-20170166867-A1 | 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-06-15 | — | — | US | disclosed |
| US-20170166867-A1 | 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-06-15 | — | — | US | disclosed |
| WO-2015119579-A1 | 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10865384-B2 | 2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis | CSNK1A1, CSNK1G1, CSNK2A1 | MAPK14 241/4885ALOX5 4450/4885CSNK1D 11/4885 |
| US-20170166867-A1 | 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS | CSNK1A1, CSNK1G1, CSNK2A1 | MAPK14 241/4885ALOX5 4450/4885CSNK1D 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.